The Wall Avenue Journal with the report 

The Novavax vaccine, it says, gives key doable benefits over its opponents:

  • early information counsel the Novavax shot could also be one of many first proven to stem asymptomatic unfold of the coronavirus
  • and likewise probably present longer-lasting safety

Its a 2 shot vaccine. Approval nonetheless seems a few months away.

An fascinating learn however the agency has clearly misplaced first-mover benefit and by the point it will get approval, then into distribution, it would nicely be too late? 

The Wall Street Journal with the report